These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15075536)

  • 1. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
    Gayà A; Esteve A; Casabona J; McCarthy JJ; Martorell J; Schulz TF; Whitby D;
    AIDS; 2004 Jan; 18(2):199-204. PubMed ID: 15075536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
    Dorak MT; Yee LJ; Tang J; Shao W; Lobashevsky ES; Jacobson LP; Kaslow RA
    J Med Virol; 2005 Jul; 76(3):302-10. PubMed ID: 15902698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.
    Katano H; Sata T; Suda T; Nakamura T; Tachikawa N; Nishizumi H; Sakurada S; Hayashi Y; Koike M; Iwamoto A; Kurata T; Mori S
    J Med Virol; 1999 Nov; 59(3):346-55. PubMed ID: 10502268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
    Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
    AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
    André S; Schatz O; Bogner JR; Zeichhardt H; Stöffler-Meilicke M; Jahn HU; Ullrich R; Sonntag AK; Kehm R; Haas J
    J Mol Med (Berl); 1997 Feb; 75(2):145-52. PubMed ID: 9083932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America.
    Fouchard N; Lacoste V; Couppie P; Develoux M; Mauclere P; Michel P; Herve V; Pradinaud R; Bestetti G; Huerre M; Tekaia F; de Thé G; Gessain A
    Int J Cancer; 2000 Jan; 85(2):166-70. PubMed ID: 10629072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Cannon MJ; Dollard SC; Black JB; Edlin BR; Hannah C; Hogan SE; Patel MM; Jaffe HW; Offermann MK; Spira TJ; Pellett PE; Gunthel CJ
    AIDS; 2003 Jan; 17(2):215-22. PubMed ID: 12545082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HHV-8 infection in patients with AIDS-related Kaposi's sarcoma in Brazil.
    Keller R; Zago A; Viana MC; Bourboulia D; Desgranges C; Casseb J; Moura WV; Dietze R; Collandre H
    Braz J Med Biol Res; 2001 Jul; 34(7):879-86. PubMed ID: 11449306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
    Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
    J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
    Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
    Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.
    Martró E; Esteve A; Schulz TF; Sheldon J; Gambús G; Muñoz R; Whitby D; Casabona J;
    Int J Cancer; 2007 Mar; 120(5):1129-35. PubMed ID: 17154170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of BC-3 and BCP-1 cell lines in immunofluorescence assay to detect HHV-8 antibodies in Kaposi's sarcoma, multiple myeloma and other groups.
    Couty JP; Ranger-Rogez S; Venot C; Jaccard A; Rogez JP; Weinbreck P; Bordessoule D; Denis F
    J Clin Virol; 1999 May; 12(3):221-31. PubMed ID: 10382819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.